Steven Cohen's position in Adma Biologics is currently worth $4.24 Million. That's 0.01% of their equity portfolio (591st largest holding). The first Adma Biologics trade was made in Q1 2020. Since then Steven Cohen bought shares five more times and sold shares on four occasions. The stake costed the investor $2.89 Million, netting the investor a gain of 47% so far.